NCT02566018 (prox_hum) is a clinical trial of treatment/medical device in Humeral Fractures, sponsored by University Hospital, Basel, Switzerland.

Who is sponsoring NCT02566018?

NCT02566018 is sponsored by University Hospital, Basel, Switzerland.

What drugs are being tested in NCT02566018?

Interventions in NCT02566018: treatment/medical device, standard.

What condition does NCT02566018 study?

NCT02566018 studies Humeral Fractures.

Is NCT02566018 still recruiting?

NCT02566018 is currently completed. Last updated 14 May 2024.

Last reviewed 2024-05-14 · How we verify

NCT02566018: prox_hum

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Treatment of Proximal Humerus Fractures in the Elderly

Completed Last updated 14 May 2024

What this trial tests

trial testing treatment/medical device in Humeral Fractures in 160 participants. Completed in 31 December 2019.

Timeline

1 May 2015

Primary endpoint
31 December 2019

31 December 2019

Quick facts

Lead sponsor	University Hospital, Basel, Switzerland
Status	Completed
Study type	OBSERVATIONAL
Enrollment	160
Start date	1 May 2015
Primary completion	31 December 2019
Estimated completion	31 December 2019
Sites	1 location across Switzerland

Drugs / interventions tested

treatment/medical device
standard

Conditions studied

Humeral Fractures — all drugs for Humeral Fractures →

Sponsor

University Hospital, Basel, Switzerland

Who can join

65 and older, any sex, with Humeral Fractures. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is set to evaluate a proposed standard for the treatment of proximal humerus fractures

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Humeral Fractures

Currently open trials in the same condition.

NCT03796572 — Regional Blocks for Lateral Condyle Fractures · Phase 4 · recruiting

Other University Hospital, Basel, Switzerland trials

Trials by the same sponsor.

NCT07444788 — Acute Effects of Intravenous 5-MeO-DMT in Healthy Participants · Phase 1 · recruiting
NCT07494214 — Acute Analgesic Effects of MDMA on Experimentally Induced Acute Pain, Hyperalgesia and Allodynia in Healthy Participants · Phase 1 · recruiting
NCT07419048 — Artificial Intelligence or Human Hand? Evaluating Inferior Vena Cava Imaging for Hydration Status · recruiting
NCT06978777 — Effect of Caffeine on Cold-stimulated Brown Adipose Tissue Activity · NA · recruiting
NCT07273630 — Effect of Protein Supplementation and Fluid Restriction on Plasma Sodium Levels in Patients Undergoing Pituitary Surgery · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02566018 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Basel, Switzerland
Last refreshed: 14 May 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02566018.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing